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Acute mesenteric ischemia accounts for only
0.1%1 of yearly hospital admissions but is associated
with a mortality rate of 15% to 70%.2 It is estimated
that thrombosis of preexisting mesenteric artery
stenoses (MAS) accounts for 20% to 50%3 of these
cases. In most retrospective studies only, acute mesen-
teric ischemia developed in only 20% to 50%4 of
patients because MAS had warning symptoms of
postprandial abdominal pain or weight loss. The nat-
ural history of MAS is unknown, and the incidental
detection of MAS during angiography in patients
without symptoms presents a management dilemma.
Some vascular surgeons, as suggested by Kaleya et
al.,4 correct significant MAS in asymptomatic patients
concomitantly with aortic reconstruction. Patients
with asymptomatic MAS who do not require aortic
surgery are observed for development of symptoms,
but this may not be an appropriate strategy.
This study was undertaken to determine the risk
of developing acute mesenteric ischemia or chronic
mesenteric ischemia in patients with significant
asymptomatic MAS. An attempt was made to identi-
fy angiographic findings and clinical factors that may
contribute to the development of these two clinical
syndromes. These results may help to improve man-
agement of patients with asymptomatic MAS.
PATIENTS AND METHODS
From 1989 through 1995, 980 consecutive
abdominal aortograms with anteroposterior and lat-
eral projections were reviewed at the time of angiog-
raphy or within 1 week of obtaining the angiograms
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to identify patients with mild (1% to 49%), moderate
(50% to 74%), or severe (75% to 99%) stenoses or
occlusion of the celiac artery (CA), superior mesen-
teric artery (SMA), or inferior mesenteric artery
(IMA). The protocol approved by the University of
Kansas Medical Center Human Subjects Committee
excluded patients with less than 50% stenoses of one
or any combination of the three mesenteric arteries.
All asymptomatic patients with moderate or
severe stenosis of the mesenteric vessels were inter-
viewed at 6-month intervals with a uniform ques-
tionnaire about development of postprandial abdom-
inal pain, weight loss, “food fear,” acid peptic dis-
ease, symptoms of cholecystitis, bowel infarction, or
death. Patients were questioned during office visits,
during hospitalizations, or by telephone. Medical
records, autopsy reports, and interviews of family
members were used to supplement information
obtained from patients. Demographic data, comor-
bid conditions, and vascular operations were record-
ed for each patient. Data were analyzed by standard
statistical methods, including c 2 analysis and Fisher’s
exact test.
RESULTS
Eighty-two patients met the inclusion criteria of
this study. Ten were lost to follow-up after the initial
interview. Of the remaining 72 patients, 42 (58%)
were male. The subjects were between 31 and 95
years old, with a mean age of 67.5 years. Peripheral
vascular disease was confirmed in 52 patients (72%),
coronary artery disease in 42 patients (58%), hyper-
tension in 48 patients (66%), and congestive heart
failure in 18 patients (25%). Thirty-two patients
(44%) were diabetic, 14 (19%) had abdominal aortic
aneurysms, 16 (22%) had renal insufficiency or fail-
ure (creatine ‡ 2.0 mg/dl), 13 (18%) had a history of
and were being treated for unexplained venous or
arterial thrombosis and were considered to have
hypercoagulable states, 19 (26%) had a history of
stroke, 11 (15%) chronic obstructive pulmonary dis-
ease, and 5 patients (7%) had hepatic disease. Sixteen
patients (22%) had a history of acid peptic disease,
but 12 were in remission.
One hundred thirteen vascular operations were
performed in these 72 patients, including 25 femoral
popliteal reconstructions, 17 coronary artery bypass
grafts, 16 carotid endarterectomies, 15 aortic recon-
structions, 11 abdominal aortic aneurysmorrhaphies,
and 29 other vascular procedures. Thirty-six (37%) of
these vascular procedures were performed in patients
before entering this study; 45 operations (40%) were
carried out at the time of angiographic identification
of MAS; and 32 (28%) vascular reconstruction pro-
cedures were performed while patients were being
observed for the development of mesenteric vascular
symptoms.
Aortography. The angiographic findings are
tabulated in Table I. In the 72 patients, the CA was
diseased more frequently (69 [96%]) than the SMA
(36 [50%]), or the IMA (41 [57%]). The CA also had
a higher degree of moderate and severe stenosis (18
[25%] and 36 [50%], respectively) than the SMA (14
[19%] and 12 [17%]) or the IMA (2 [3%] and 16
[22%]). There was a higher percentage of occluded
IMAs (22 [31%]) than SMAs (5 [7%]) and CAs (11
[15%]). No patient had an isolated stenosis or occlu-
sion of the inferior mesenteric artery.
Data from 12 patients with mild MAS (<50%
stenosis) in one or more vessels in combination with
more severe lesions were not included in most analy-
ses, because mild lesions represent a gray zone in
terms of hemodynamic significance. The remaining
60 patients were found to have six distinct patterns
(Table II) of significant MAS (>50% stenosis or
occlusion). Twenty (33%) of the 60 patients had sig-
nificant stenoses (16) or occlusion (4) of only the
CA or SMA. Twenty-five patients (42%) had signifi-
cant stenoses or occlusion of two arteries. Fifteen
patients (25%) had significant stenoses (14) or
occlusion (1) of all three mesenteric arteries.
Comorbid conditions. The comorbid condi-
tions of the 60 patients included in this study and
their distribution according to arterial disease pat-
tern are presented in Table III. No statistically sig-
nificant correlations were found between particular
patterns and the presence of specific or total num-
bers of comorbid factors.
Table I. Angiographic findings for 72 patients
Finding Celiac artery Superior mesenteric artery Inferior mesenteric artery
Normal 3 (4%) 36 (50%) 31 (43%)
Mild (1%–49%) 4 (6%) 5 (7%) 1 (1.3%)
Moderate(50%–74%) 18 (25%) 14 (19%) 2 (3%)
Severe(75%–99%) 36 (50%) 12 (17%) 16 (22%)
Occluded 11 (15%) 5 (7%) 22 (31%)
Total 72 72 72
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Clinical follow-up. Follow-up ranged from 1 to
6 years (mean, 2.6 years). The duration of follow-up
is presented by life table analysis in Fig. 1.
Gastrointestinal complaints were common but gener-
ally nonspecific and inconsistent in character and
duration. Seventeen patients (28%) had gastrointesti-
nal symptoms from proven gastrointestinal disorders,
including Crohn’s disease (1), gastroesophageal
reflux disease (3), diabetic gastroparesis (3), portal
hypertension (1), medication-induced disorders (2),
diverticulitis (2), pseudomembranous colitis (1), and
peptic ulcer disease (4). The four patients with peptic
ulcer disease had resolution of symptoms with med-
ical treatment. No patient had symptoms compatible
with cholecystitis. Eight (47%) of these 17 patients
had significant CA disease, and 5 (29%) had signifi-
cant disease of all three arteries. None of these
patients has had progression of symptoms with a
mean duration of follow-up of 36 months, but two
were deceased at 12 and 36 months. No significant
correlation was found between the number of gas-
trointestinal symptoms and the pattern of mesenteric
arterial disease.
Mesenteric ischemia developed in 4 (6%) of the
60 patients. Each of these four patients had severe
stenosis or occlusion of the CA, SMA, and IMA.
Four (27%) of the 15 patients with three-vessel
arterial disease had mesenteric ischemia, compared
with none of the 45 other patients with significant
MAS (p = 0.0028). One of these four patients, a
57-year-old man, died of acute bowel necrosis 1
week after hospitalization for the evaluation of
severe ischemia of the right lower extremity. This
patient had no symptoms of chronic mesenteric
ischemia during that hospitalization and remained
asymptomatic until he presented with an acute
abdomen and was found at laparotomy to have
necrosis of the gut from stomach to rectum. The
other three patients, two men who were 47 and 46
years old and one woman who was 82 years old,
had intestinal angina consistent with chronic
mesenteric ischemia at 7, 24, and 24 months of
follow-up, respectively. Two of these three patients
underwent successful aortic-celiac-superior mesen-
teric artery reconstruction; one patient refused the
operation.
Table II. Location of arterial disease in 60 patients
with significant mesenteric stenosis
Arterial disease Number of patients
SMA 1
CA 19
SMA & CA 5
SMA & IMA 2
CA & IMA 18
CA & SMA & IMA 15
SMA, Superior mesenteric artery; CA, celiac artery; IMA, inferi-
or mesenteric artery.
Fig. 1. Patient follow-up by life table analysis.
Table III. Location of arterial disease and comorbid condition
Comorbid condition SMA CA SMA, CA SMA, IMA CA, IMA CA, SMA, IMA Total
Total patients 1 19 5 2 18 15 60
Diabetes mellitus 0 7 1 1 6 4 19
Congestive heart failure 1 6 2 0 7 5 21
Hypertension 0 11 4 0 12 12 39
Hypercoaguable state 0 4 1 0 3 3 11
Liver disease 0 2 0 0 1 1 4
Chronic obstructive pulmonary disease 0 2 1 1 3 2 9
Renal failure 0 3 1 1 3 5 13
Peptic ulcer disease 0 8 1 0 2 3 14
Cerebrovascular accident 1 3 0 0 3 7 14
Coronary artery disease 1 8 1 1 10 10 31
Peripheral vascular disease 1 12 3 2 9 13 40
SMA, Superior mesenteric artery; CA, celiac artery; IMA, inferior mesenteric artery.
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Twenty-nine (40%) of the 72 patients with sig-
nificant mesenteric arterial disease died during the
study (mean survival, 1.9 years). One death was a
result of acute mesenteric ischemia. Causes of death
in the remaining 28 patients included congestive
heart failure (5), acute myocardial infarction (7),
postoperative AAA repair (5), respiratory failure (2),
lung cancer (2), end-stage hepatic or renal disease
(4), pulmonary embolism (2), and pancreatic cancer
(1). Deaths after abdominal aortic aneurysm repair
resulted from myocardial infarction in three patients,
renal failure in one patient, and multisystem organ
failure in one patient. No clinical evidence of intesti-
nal ischemia was present in these five patients.
Deaths in the 60 patients with distinct patterns
of MAS are tabulated in Table IV. Thirty-three per-
cent of patients (5 of 15) with significant three-ves-
sel disease, 38% of patients (7 of 18) with significant
combined CA and IMA disease, and 40% of patients
(2 of 5) with CA and SMA disease died during fol-
low-up. There were no significant statistical correla-
tions between the disease pattern and the risk of
death. The high mortality rate (40%) documented in
this study reflects the severity of cardiovascular dis-
ease in patients with MAS.
Two patients underwent aortomesenteric by-
passes during aortic surgery for occlusive and
aneurysmal disease. In one patient with occlusion
of the SMA, severe stenosis of the IMA, moderate
celiac artery stenosis, and 90% stenosis of both
renal arteries, bilateral aortorenal artery recon-
struction was combined with celiac reconstruction
and aortomesenteric grafting. Both patients recov-
ered uneventfully.
DISCUSSION
The clinical course of patients with asymptomatic
mesenteric stenosis has not been previously described.
Several retrospective studies3,5 estimate that 20% to
50% of cases of acute mesenteric ischemia are a result
of thrombosis of preexisting MAS, but no report
describes a cohort of patients with varied patterns of
mesenteric disease that has been followed to detect
acute or chronic gastrointestinal ischemia.
Our study documents the clinical course of 72
patients with asymptomatic mesenteric stenosis.
Sixty of these patients had specific patterns of signif-
icant stenosis involving one, two, or all three mesen-
teric arteries. Mesenteric ischemia developed in only
four patients. Each of these four patients had signif-
icant three-vessel disease. Eight of the 15 patients
with significant three-vessel disease had mesenteric
ischemia (4) or died (5) as a consequence of other
vascular problems; one of the patients who had
mesenteric ischemia died. Seventeen other patients,
15 of whom are still alive, had gastrointestinal symp-
toms, none of which suggested mesenteric ischemia.
Of particular interest was the development of
chronic or acute mesenteric ischemia only in patients
with significant three-vessel arterial disease; this
occurred in 27% of patients with this disease pattern.
Thirty-three percent of these patients had other gas-
trointestinal symptoms, and five of the patients with
significant three-vessel arterial disease died. The inci-
dence of symptomatic mesenteric ischemia might have
been higher had these five patients lived. Mesenteric
ischemia, other gastrointestinal symptoms, and death
affected 86% of patients with three-vessel arterial dis-
ease, suggesting that these patients deserve frequent
clinical evaluations and that symptoms, regardless of
their intensity or character, should be thoroughly
investigated. Angiography may be of little value for
patients with three-vessel MAS. Prophylactic mesen-
teric arterial reconstruction is a reasonable considera-
tion for this group of patients. Those undergoing aor-
tic reconstruction for aneurysmal or occlusive disease
who have three-vessel MAS should have concomitant
mesenteric arterial revascularization.
Although this study was not designed to define
the optimal interval or method of evaluating patients
with known MAS, it seems reasonable to suggest
that patients with one- or two-vessel disease should
be interviewed every 6 months. The development of
gastrointestinal symptoms should result in a thor-
ough evaluation, including endoscopy, sonography,
and a duplex ultrasound study of the celiac and supe-
rior mesenteric arteries. If a clear cause for the gas-
trointestinal symptoms is not identified, aortography
with careful anteroposterior and lateral views is indi-
cated. Progression of disease identified by angiogra-
phy should be adequate evidence to proceed with
mesenteric arterial reconstruction.
Table IV. Mortality
Number Number with
Pattern of vascular disease of deaths significant disease
SMA 1 1
CA 4 19
SMA & CA 2 5
SMA & IMA 0 2
CA & IMA 7 18
CA & SMA & IMA 5 15
Total 19 (32%) 60
SMA, Superior mesenteric artery; CA, celiac artery; IMA, inferi-
or mesenteric artery.
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Dr. Bruce L. Gerwertz (Chicago, Ill.). I note that the
conclusions have become increasingly strident from the
time the abstract was presented to time of the presenta-
tion, and I would agree with the evolution of their
thoughts. The prevalence of atherosclerotic lesions in the
mesenteric circulation is unquestioned. In a study, which
is a classic by Jimenez and colleagues from New York, the
prevalence of atherosclerotic lesions in these vessels was as
high as 50% in patients who were more than the age of 70
years in an autopsy series of unselected patients.
In our practices, we all have recognized that acute
mesenteric ischemia can occur without prodromal symp-
toms. Although the outcome of such a catastrophic event
is often quite poor, the incidence is relatively low when
considering the large population at risk. In this study, on
the basis of more than 900 arteriograms, the authors
attempt to better define this risk. The provocative ques-
tion that arises from these data is whether prophylactic
operation should be considered in patients with mesen-
teric arterial lesions unassociated with symptoms. The pre-
sentation and the manuscript are clear.
I would place a slightly different spin on the results,
although my spin is becoming increasingly closer to the
ideas of Dr. Thomas and his colleagues. A relatively small
number of patients had critical lesions of the most signifi-
cant visceral artery, the superior mesenteric artery. Only
17% or 24% of the 72 patients with lesions had severely
stenosed or occluded superior mesenteric arteries. Fifteen
of these patients had significant arterial disease in all three
vessels. A noteworthy fact is that mesenteric ischemia
developed in four of these 15 previously asymptomatic
patients within the relatively short follow-up of 2.6 years.
Furthermore, five of these patients died during this fol-
low-up, including the one patient with intestinal infarc-
tion. Hence, by my count, eight of the 15 patients with all
three vessel involvements either died from complications
of atherosclerosis so they were not at risk for mesenteric
events for the full follow-up period or they developed
mesenteric ischemia. To assume therefore that had these
additional four patients not died from coronary artery dis-
ease more than four patients could have developed mesen-
teric ischemia would not be unreasonable. Indeed, per-
haps the most striking finding of this study was the extra-
ordinary mortality rate in the selected group of patients
with atherosclerotic disease. One-third of the 60 patients
with any significant mesenteric involvement including sin-
gle vessel disease died during this relatively short period of
time. The authors appropriately acknowledge that addi-
tional follow-up will be required on this select group of
patients. Nonetheless, on the basis of the data presented
today, I believe a reasonable case could be made for
mesenteric revascularization in asymptomatic patients with
involvement of both the celiac and superior mesenteric
artery and with tolerable cardiac risk. I wish to ask the
authors whether this is consistent with their current clini-
cal approach.
Finally, an interesting situation that faces many of us in
clinical practice is the need to perform infrarenal aortic
surgery on patients with asymptomatic but high grade
celiac and superior mesenteric artery lesions. Our practice
at the University of Chicago has been to selectively per-
form revascularization to one or both of those vessels if
operative time is not unnecessarily prolonged. I wish to
ask the authors whether that is their current practice as
well. I enjoyed the manuscript and the excellent presenta-
tion, and I thank you for the chance to comment. 
Dr. James H. Thomas. Thank you for those nice com-
ments. We certainly agree with that interpretation of the
data. Our thinking about this particular entity represents
an evolution in our practice. We have not yet applied our
suggestions to our patients, but we do expect to begin to
apply this particular approach to our patient population.
Yes, we in fact do reconstruct the mesenteric vessels at the
time of aortic reconstruction as I believe the majority of
vascular surgeons do at this time. Thank you again for
your attention.
DISCUSSION
The management suggestions regarding patients
with one- or two-vessel MAS are speculative.
Although the incidence of symptomatic mesenteric
ischemia documented in retrospective studies is appar-
ently low among these patients, continued follow-up
of the cohorts in this study may reveal specific patterns
of mesenteric artery disease in patients with one- or
two-vessel disease that are associated with an increased
risk of mesenteric ischemia or death.
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